Liposomal formulations

Liposomal formulations, also referred to as liposomal preparations, are systems that use liposomes to incorporate and carry substances. Liposomes are vesicles composed of one or more lipid bilayers surrounding an aqueous compartment, allowing molecules to associate with the internal aqueous phase, the lipid membrane or the vesicle surface depending on their properties and the formulation design.

This organization distinguishes a liposomal formulation from a simple solution or suspension. The active substance and formulation components can interact with the liposomal structure, potentially affecting properties such as stability, release, availability and distribution.

How are liposomes formed?

Liposomes are commonly made from amphiphilic lipids, particularly phospholipids. These molecules contain regions with different affinities for water and can organize into bilayer structures in an aqueous environment. The resulting vesicle contains an aqueous interior separated from the surrounding medium by a lipid membrane.

Water-soluble compounds may be located predominantly in the aqueous compartment, whereas lipophilic compounds may associate with the lipid bilayer. This distinction is not absolute. The location and physical state of a substance depend on its physicochemical properties, lipid composition and the manufacturing or loading process.

Unilamellar and multilamellar liposomes

Bilayer organization is an important structural characteristic. Unilamellar liposomes contain a single lipid bilayer surrounding the aqueous compartment, whereas multilamellar liposomes contain multiple concentric bilayers. Vesicle size, morphology and lamellarity can influence loading capacity, stability and formulation behavior.

Therefore, stating that a formulation contains liposomes does not fully characterize the system. Liposomal products containing the same active substance may behave differently when lipid composition, vesicle size, bilayer structure or the physical state of the incorporated substance changes.

Particle size, size distribution and PDI

Liposome size and size distribution are major characterization parameters. For submicron systems, techniques such as dynamic light scattering can be used to determine hydrodynamic size and the polydispersity index, commonly abbreviated as PDI.

PDI provides information about the breadth of the size distribution but should not be considered a complete measure of formulation quality by itself. Measurement method, concentration, aggregates and the optical properties of the sample can influence the reported result.

Zeta potential and surface properties

Zeta potential is another parameter frequently measured during liposome characterization. It describes an electrokinetic property of dispersed particles and can provide information about interactions between the vesicle interface and the surrounding medium.

The measured value can change with lipid composition, surface groups, pH, ionic strength and composition of the continuous phase. Zeta potential should therefore not be treated as a fixed intrinsic property of a liposome independent of measurement conditions.

Encapsulation efficiency and free drug

For liposomal drug formulations, total active-substance content must often be distinguished from the fraction actually associated with or entrapped in the liposomes. Encapsulation efficiency describes the proportion incorporated into the liposomal system according to the analytical definition used.

Differentiating free and encapsulated fractions is important because they may have different behavior. Leakage during storage or release after exposure to a particular medium can also change the relationship between free and liposome-associated material.

Which parameters are important for liposome characterization?

Characterization can involve several attributes depending on the formulation and its intended purpose:

• mean vesicle size and size distribution;
• polydispersity index;
• morphology and lamellarity;
• lipid composition and lipid ratios;
• zeta potential or other surface-related properties;
• free and encapsulated active substance;
• encapsulation efficiency;
• vesicle aggregation or fusion;
• leakage and drug release behavior;
• physical and chemical stability during storage.

For parenteral products, additional dosage-form quality attributes such as sterility, endotoxins and unwanted particulate matter may also require appropriate control.

What are liposomal formulations used for?

Liposomal formulations are widely studied and used as formulation and drug-delivery systems. They can help incorporate substances with particular solubility or stability challenges, modify exposure to an active substance and influence how the compound remains associated with a carrier before release.

However, placing an active substance in a liposome does not automatically provide controlled release, improved efficacy or specific tissue targeting. These outcomes depend on formulation composition, vesicle structure, stability, administration route and interactions with the biological environment.

Frequently asked questions about liposomal formulations

What is the difference between a liposome and a liposomal formulation?

A liposome is the lipid-bilayer vesicle itself. A liposomal formulation is the complete preparation containing the vesicles together with the active substance, aqueous phase, lipids and any other formulation components.

Are liposomal formulations always nanoparticles?

No. Many modern liposomal systems are designed in the nanometer size range, but liposomes can occur over different size ranges. Classification should be based on the measured dimensions and characteristics of the specific preparation.

Which tests are important for liposome characterization?

Particle size, size distribution, PDI, morphology, lipid composition, zeta potential, free and encapsulated drug, encapsulation efficiency, stability and release behavior are among the parameters that may be relevant depending on the formulation.